3 completed, 3 terminated. 3 Phase 2, 1 Not applicable, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Spirig Pharma Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sertaconazole 2% Cream to Improve Symptoms Associated With Atopic Dermatitis Sertaconazole 2% cream, Placebo - Skin Alterations Associated With Atopic Dermatitis | Phase 2 | Completed | Spirig Pharma Ltd. | 70 | 2013-02-01 | 2015-05-20 |
| Efficacy and Safety Trial of Topical Resiquimod Gel (0.06%) in Patients With Nodular Basal Cell Carcinoma 0.06% Resiquimod Gel - A, 0.06% Resiquimod Gel - B, 0.06% Resiquimod Gel - C - Nodular Basal Cell Carcinoma | Phase 1 / Phase 2 | Terminated | Spirig Pharma Ltd. | 4 | 2013-02-01 | 2016-06-22 |
| Observational Trial Tolerability and Efficacy of Resiquimod Gel in Patients Treated for Actinic Keratosis. Actinic Keratosis | Terminated | Spirig Pharma Ltd. | 16 | 2013-01-01 | 2016-08-03 | |
| Dose-finding, Safety, Efficacy Trial of Topical Resiquimod in Patients With Multiple Actinic Keratosis Lesions Resiquimod 0.03%, Resiquimod 0.01%, placebo - Actinic Keratosis | Phase 2 | Completed | Spirig Pharma Ltd. | 218 | 2012-05-01 | 2015-12-15 |
| Prevention of UV-induced Carcinogenic Skin Alterations in Immunosuppressed Solid Organ Transplanted Patients MD-3511356, Standard Sun Protection Measures - Actinic Keratoses, Squamous Cell Carcinomas | Phase 3 | Terminated | Spirig Pharma Ltd. | 244 | 2010-11-01 | 2016-01-08 |
| Sunscreens in Patients With Cutaneous Lupus Erythematosus(CLE) UV A and B irradiation - Cutaneous Lupus Erythematosus | Not applicable | Completed | Spirig Pharma Ltd. | 20 | 2009-11-01 | 2016-03-09 |
Keratosis, Actinic (3) · Carcinoma, Squamous Cell (1) · Dermatitis, Atopic (1) · Lupus Erythematosus, Cutaneous (1)
sertaconazole (1)
Germany (6) · Switzerland (4) · Austria (1) · Czechia (1) · France (1) · Ireland (1) · Netherlands (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Lars E French, MD (2) · Annegret Kuhn, MD (1) · Claas Ulrich, MD (1) · R Dummer, PrMD (1)